Pediatric Furosemide Dosing
For pediatric patients, the initial dose of furosemide is 1 mg/kg given intravenously or intramuscularly, administered slowly under close medical supervision, with the option to increase by 1 mg/kg increments (not sooner than 2 hours after the previous dose) up to a maximum of 6 mg/kg, though premature infants should not exceed 1 mg/kg/day. 1, 2
Route-Specific Dosing
Intravenous/Intramuscular Administration
- Initial dose: 1 mg/kg body weight 1, 2
- Administration: Give slowly under close medical supervision
- Dose escalation: May increase by 1 mg/kg increments if diuretic response is inadequate
- Timing between doses: Wait at least 2 hours before increasing dose
- Maximum dose: 6 mg/kg body weight (do not exceed) 1, 2
- Special population - Premature infants: Maximum 1 mg/kg/day 1, 2
Oral Administration
- Initial dose: 2 mg/kg every 12 hours 3
- This reflects the standard 1:2 IV-to-oral conversion ratio
- Recent evidence supports this conversion produces comparable diuretic effects in infants with established bronchopulmonary dysplasia 4
Clinical Context and Guidelines
Heart Failure Management
The Canadian Cardiovascular Society guidelines specifically recommend furosemide for pediatric heart failure with congestion at 0.5-1 mg/kg intravenously or orally every 6-12 hours as a safe and effective starting dose 5. This represents a more conservative initial approach compared to the FDA labeling, which may be preferable when initiating therapy in stable patients.
Continuous vs. Intermittent Dosing
For critically ill infants post-cardiac surgery, continuous infusion at 0.1 mg/kg/hour produces comparable urinary output with lower total drug dose and less hemodynamic fluctuation compared to 1 mg/kg boluses every 4 hours 6. This approach minimizes fluid replacement needs and provides more stable diuresis.
Critical Pharmacodynamic Considerations
The relationship between furosemide urinary excretion rate and diuretic effect is steep in infants, meaning higher doses may not significantly increase diuretic response in those with normal renal function 7. The minimum effective urinary excretion rate is approximately 0.58 mcg/kg/min 7.
Age-Specific Responses
- Infants: Demonstrate very steep dose-response curves to 1 mg/kg IV, suggesting limited benefit from dose escalation 7
- Older children: May tolerate and require higher doses for adequate response
- The dose-response relationship varies significantly by disease state and route of administration 8, 7
Important Safety Warnings
Premature Infant Restrictions
The 1 mg/kg/day maximum for premature infants is critical due to risks of:
- Cholelithiasis (especially with concurrent total parenteral nutrition) 8
- Secondary hyperparathyroidism and bone disease with long-term use 8
- Nephrocalcinosis
Monitoring Requirements
- Electrolytes: Particularly potassium and sodium
- Renal function: Serum creatinine is a significant predictor of diuretic response 9
- Fluid status: Assess for dehydration, which can occur rapidly even at standard doses 10
- Blood pressure: Monitor for hypotension
Administration Precautions
- IV doses must be given slowly (1-2 minutes) to prevent ototoxicity 1, 2
- Parenteral therapy should be replaced with oral therapy as soon as practical 1, 2
- Do not use if solution is discolored 2
Common Pitfalls to Avoid
Exceeding 6 mg/kg in children or 1 mg/kg/day in premature infants - these limits are absolute contraindications per FDA labeling 1, 2
Rapid IV administration - always give over 1-2 minutes to minimize adverse effects
Inadequate monitoring - infants can develop significant dehydration requiring saline infusion within 3 hours of a 1 mg/kg dose 10
Assuming linear dose-response - particularly in infants with normal renal function, where the steep dose-response curve suggests diminishing returns with dose escalation 7
Using acidic solutions concurrently - furosemide precipitates at pH <7; never mix with labetalol, ciprofloxacin, amrinone, or milrinone in the same IV line 1, 2